About Acpharis
Acpharis is a company based in Holliston (United States) founded in 2008. Acpharis offers products and services including Computational Solvent Mapping, Protein-Protein Docking, and Customized Services. Acpharis operates in a competitive market with competitors including NantHealth, BioAge Labs, Genedata, Perthera and Dandelion Health, among others.
- Headquarter Holliston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$403.09 K (USD)19.31as on Mar 31, 2022
-
Net Profit
$26.11 K (USD)-14.87as on Mar 31, 2022
-
EBITDA
$31.2 K (USD)28.43as on Mar 31, 2022
-
Latest Funding Round
$202.27 K (USD), Grant
Sep 04, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acpharis
Acpharis offers a comprehensive portfolio of products and services, including Computational Solvent Mapping, Protein-Protein Docking, and Customized Services.
Tool to identify druggable binding sites for early-stage drug discovery.
Software for modeling protein interactions in research applications.
Tailored modeling services for drug discovery needs.
Funding Insights of Acpharis
Investors in Acpharis
Acpharis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Acpharis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acpharis
Investment portfolio details for Acpharis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acpharis
Detailed financials for Acpharis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acpharis Comparisons
Peer comparison for Acpharis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acpharis
Acpharis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NantHealth, BioAge Labs, Genedata, Perthera and Dandelion Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Bioinformatics platforms are provided for cancer treatment identification.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Software solutions are developed for drug discovery and life sciences.
|
|
| Locked | Locked | Locked |
Molecular cancer profiling is conducted via genomics and proteomics.
|
|
| Locked | Locked | Locked |
AI-powered real-world data platform is provided for clinical development.
|
|
| Locked | Locked | Locked |
Predictive data analysis software is developed for researchers.
|
Detailed competitors of Acpharis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acpharis
Complete news archive for Acpharis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acpharis
Acpharis was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Acpharis is headquartered in Holliston, United States. It is registered at Holliston, Massachusetts, United States.
Annual revenue of Acpharis is $403.09K as on Mar 31, 2022.
Acpharis is focussed on providing early-stage drug discovery services which include homology modeling of proteins, high throughput virtual screening of databases, and the assessment of compounds in libraries. It has developed two technologies namely Piper which elucidates the details of specific protein interactions at the atomic level and Atlas which is used for the computational mapping of proteins using organic solvents as probes. It has received an SBIR grant to produce software for modeling and optimization of protein therapeutics.
Acpharis's top competitors include NantHealth, BioAge Labs and Genedata.
Acpharis offers Computational Solvent Mapping, Protein-Protein Docking, and Customized Services.
Acpharis has 1 investor. Key investors include HHS.